Pharmaceutical
| Wed 17 Jun 2026
Taipei, June 17 -- Antengene Biologics Ltd has applied Taiwan patent for Novel Antibodies That Bind to CD3 and LILRB4, and Uses Thereof. Gao Meng-shi, Chen Peng, Yuwen Hui, Guo Rong, Liu Hui-ling, Hou Bing, Shan Bo, Mei Jay, Sun Ao and Hu Zao-shun developed it.
The patent application number is TW20240147487 20241206. The pate..